Madhu Singh

Madhu Singh is an advisor at VoxCell BioInnovation. Prior to their current position, they were the director of clinical and regulatory affairs at SignalChem Lifesciences Corporation from April 2012 to December 2015. There, they successfully led the company's lead candidate into Phase 1 clinical trials. From January 2016 to December 2018, they were the head of regulatory and clinical affairs at Welichem Biotech Inc. where they provided full clinical trial management for an oncology program that was licensed in by the company. Madhu is experienced in protocol development, clinical development strategy and planning, and overseeing the budget and scope of projects.

Madhu Singh has a PhD in Molecular Biology from Simon Fraser University and a Master of Science in Biochemistry and Molecular Biology from Delhi University.